0001562180-17-000222.txt : 20170111
0001562180-17-000222.hdr.sgml : 20170111
20170111163059
ACCESSION NUMBER: 0001562180-17-000222
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170109
FILED AS OF DATE: 20170111
DATE AS OF CHANGE: 20170111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLAUKOS Corp
CENTRAL INDEX KEY: 0001192448
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
BUSINESS PHONE: 949-367-9600
MAIL ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
FORMER COMPANY:
FORMER CONFORMED NAME: GLAUKOS CORP
DATE OF NAME CHANGE: 20020925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calcaterra Chris M.
CENTRAL INDEX KEY: 0001640771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37463
FILM NUMBER: 17523233
MAIL ADDRESS:
STREET 1: C/O GLAUKOS CORPORATION
STREET 2: 26051 MERIT CIRCLE, SUITE 103
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-01-09
false
0001192448
GLAUKOS Corp
GKOS
0001640771
Calcaterra Chris M.
C/O GLAUKOS CORPORATION
229 AVENIDA FABRICANTE
SAN CLEMENTE
CA
92672
false
true
false
false
Chief Commercial Officer
Common Stock
2017-01-09
4
M
false
20000.00
7.275
A
260000.00
D
Common Stock
2017-01-09
4
S
false
20000.00
38.02
D
240000.00
D
Stock Options (Right to buy)
7.275
2017-01-09
4
M
false
20000.00
0.00
D
2024-07-10
Common Stock
20000.00
18136.00
D
These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
This transaction was executed in multiple trades at prices ranging from $38.00 to $38.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option, which represented the right to purchase a total of 110,000 shares, has a two-year vesting schedule in which 75% vested on July 10, 2015, the first anniversary of the grant date, and the remainder vested equally for 12 months thereafter, such that the stock option vested in full on July 31, 2016, the second anniversary of the grant date.
/s/ Richard L. Harrison, Attorney-in-Fact
2017-01-11